Market: NASD |
Currency: USD
Address: N/A
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
📈 VanEck Pharmaceutical ETF Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2025 |
- |
$0.607000 |
- |
2025-07-01 |
- |
Dividend payout |
$0.525000 |
- |
2025-04-01 |
- |
Dividend payout |
Total Amount for 2025: $1.132000 |
2024 |
- |
$0.411000 |
- |
2024-12-27 |
- |
Dividend payout |
$0.409000 |
- |
2024-10-01 |
- |
Dividend payout |
$0.356000 |
- |
2024-07-01 |
- |
Dividend payout |
$0.533000 |
- |
2024-04-01 |
- |
Dividend payout |
Total Amount for 2024: $1.709000 |
2023 |
- |
$0.307000 |
- |
2023-12-27 |
- |
Dividend payout |
$0.340000 |
- |
2023-10-02 |
- |
Dividend payout |
$0.389000 |
- |
2023-07-03 |
- |
Dividend payout |
$0.664000 |
- |
2023-04-03 |
- |
Dividend payout |
Total Amount for 2023: $1.700000 |
2022 |
- |
$0.240000 |
- |
2022-12-28 |
- |
Dividend payout |
$0.270000 |
- |
2022-10-03 |
- |
Dividend payout |
$0.250000 |
- |
2022-07-01 |
- |
Dividend payout |
$0.443000 |
- |
2022-04-01 |
- |
Dividend payout |
Total Amount for 2022: $1.203000 |
2021 |
- |
$0.269000 |
- |
2021-12-29 |
- |
Dividend payout |
$0.345000 |
- |
2021-10-01 |
- |
Dividend payout |
$0.286000 |
- |
2021-07-01 |
- |
Dividend payout |
$0.350000 |
- |
2021-04-01 |
- |
Dividend payout |
Total Amount for 2021: $1.250000 |
📅 Earnings & EPS History for VanEck Pharmaceutical ETF
No earnings history available for this symbol.
📰 Related News & Research
No related articles found for "vaneck pharmaceutical".